MEDIPOST Co., Ltd. (KOSDAQ 078160), a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for the commercialization of ...
Paramount Skydance Corporation ("Paramount") today has amended its $30 per share all-cash offer for Warner Bros. Discovery, Inc. ("WBD"), to address WBD's stated concerns regarding Paramount's ...
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Nova Minerals Limited (Nasdaq:NVA) on the RedChip Small Stocks, Big Money™ show, a sponsored program on ...
An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas. KJ Muldoon is walking and getting ready to celebrate ...
X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...
JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...
Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...
A miracle baby who was treated with a pioneering gene-therapy at CHOP has reached a major milestone as he took his first ...
The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...
A baby born with a rare genetic disorder has taken his first steps after receiving a groundbreaking, personalized gene ...
A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback